There are more than 10 million children and adults with primary immunodeficiency worldwide; more than one half million in the United States, and more than a million in India.
Foundation for Primary Immunodeficiency (FPID) was established in the US to support the education, early diagnosis, genetic counseling, therapy, and research of PID in both India and the United States.
Some Facts About PID
Though PIDs are 4 times more common than hemophilia, twice common as cystic fibrosis, and almost as common as multiple sclerosis, yet very few people and physicians know about PIDs. Therefore, there is a great need to educate the population in general regarding warning signs of PIDs, and practicing physicians to diagnose and treat these patients to prevent complications and death. In India, there are very few institutions where patients with PIDs are diagnosed or treated; the majority of patients remained undiagnosed and die, contributing in part to India’s high infant mortality rate.
This event is the main opportunity for the foundation to raise funds to support its mission of education, early diagnosis, and treatment of primary immunodeficiency diseases in India and the U.S.
2024 Gala Banquet and Entertainment (black-tie option) will be eld on the 9th November at VEA Newport Beach, California.
To recognize Dr. Waldmann’s contribution to the science of primary immunodeficiency, the Foundation has established the Thomas Waldmann Memorial Award for Excellence in Human Immunology.
The Foundation has recently endowed William E. Paul Memorial Lecture and Award for Excellence in Immunology and Cell Biology in recognition of major contributions made by Dr. Paul.
The Foundation supports many activities in the US and India and has established FPID Centers in India. Click here to learn more about the different efforts supported by FPID.